Xuyang Dai

566 total citations
10 papers, 439 citations indexed

About

Xuyang Dai is a scholar working on Epidemiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Xuyang Dai has authored 10 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Xuyang Dai's work include Liver Disease Diagnosis and Treatment (5 papers), Liver physiology and pathology (3 papers) and Liver Disease and Transplantation (2 papers). Xuyang Dai is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Liver physiology and pathology (3 papers) and Liver Disease and Transplantation (2 papers). Xuyang Dai collaborates with scholars based in China. Xuyang Dai's co-authors include Cheng Peng, Lihong Gong, Naihua Hu, Yunxia Li, Cheng Wang, Mengting Zhou, Xingtao Zhao, Meichen Liu, Chaocheng Guo and Yunxia Li and has published in prestigious journals such as Journal of Ethnopharmacology, European Journal of Pharmacology and Frontiers in Pharmacology.

In The Last Decade

Xuyang Dai

10 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuyang Dai China 9 182 145 101 70 67 10 439
Mengjuan Wei China 12 227 1.2× 146 1.0× 147 1.5× 72 1.0× 53 0.8× 25 522
Naihua Hu China 9 181 1.0× 141 1.0× 98 1.0× 36 0.5× 78 1.2× 11 425
Pin‐Ho Pan Taiwan 12 171 0.9× 117 0.8× 116 1.1× 31 0.4× 69 1.0× 15 480
Shu-Ju Wu Taiwan 10 199 1.1× 115 0.8× 121 1.2× 34 0.5× 46 0.7× 10 438
Yue‐Rong Ma China 9 159 0.9× 124 0.9× 111 1.1× 52 0.7× 45 0.7× 15 476
Kyung Hwan Jegal South Korea 13 348 1.9× 118 0.8× 74 0.7× 53 0.8× 66 1.0× 30 601
Maysa A. Mobasher Saudi Arabia 12 211 1.2× 79 0.5× 114 1.1× 39 0.6× 39 0.6× 32 514
Eungyeong Jang South Korea 14 192 1.1× 89 0.6× 100 1.0× 52 0.7× 77 1.1× 39 446
Xinyu Deng China 13 201 1.1× 127 0.9× 103 1.0× 32 0.5× 33 0.5× 23 513
Jiong Jiang China 10 174 1.0× 117 0.8× 61 0.6× 50 0.7× 31 0.5× 24 483

Countries citing papers authored by Xuyang Dai

Since Specialization
Citations

This map shows the geographic impact of Xuyang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuyang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuyang Dai more than expected).

Fields of papers citing papers by Xuyang Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuyang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuyang Dai. The network helps show where Xuyang Dai may publish in the future.

Co-authorship network of co-authors of Xuyang Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Xuyang Dai. A scholar is included among the top collaborators of Xuyang Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuyang Dai. Xuyang Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dai, Xuyang, Jing Yang, Changjian Wang, et al.. (2025). Bioactive components and mechanisms of the traditional Chinese herbal formula Xuefu Zhuyu formula in the treatment of cardiovascular and cerebrovascular diseases. Journal of Ethnopharmacology. 348. 119873–119873. 2 indexed citations
2.
Gong, Lihong, Li Liao, Xuyang Dai, et al.. (2021). The dual role of immune response in acetaminophen hepatotoxicity: Implication for immune pharmacological targets. Toxicology Letters. 351. 37–52. 10 indexed citations
4.
Wang, Cheng, Naihua Hu, Lihong Gong, et al.. (2020). 2,3,5,4'-tetrahydroxystilbence-2-O-β-D-glucoside attenuates hepatic steatosis via IKKβ/NF-κB and Keap1-Nrf2 pathways in larval zebrafish. Biomedicine & Pharmacotherapy. 127. 110138–110138. 17 indexed citations
5.
Gong, Lihong, Xiaohong Gong, Cheng Wang, et al.. (2020). Exploration of anti-inflammatory mechanism of forsythiaside A and forsythiaside B in CuSO4-induced inflammation in zebrafish by metabolomic and proteomic analyses. Journal of Neuroinflammation. 17(1). 173–173. 48 indexed citations
6.
Hu, Naihua, Chaocheng Guo, Xuyang Dai, et al.. (2020). Forsythiae Fructuse water extract attenuates liver fibrosis via TLR4/MyD88/NF-κB and TGF-β/smads signaling pathways. Journal of Ethnopharmacology. 262. 113275–113275. 41 indexed citations
7.
Zhou, Mengting, Ying Deng, Meichen Liu, et al.. (2020). The pharmacological activity of berberine, a review for liver protection. European Journal of Pharmacology. 890. 173655–173655. 82 indexed citations
8.
Zhao, Xingtao, Lihong Gong, Cheng Wang, et al.. (2020). Quercetin mitigates ethanol-induced hepatic steatosis in zebrafish via P2X7R-mediated PI3K/ Keap1/Nrf2 signaling pathway. Journal of Ethnopharmacology. 268. 113569–113569. 62 indexed citations
9.
Gong, Lihong, Cheng Wang, Naihua Hu, et al.. (2020). <p>Radix Polygoni Multiflori and Its Main Component Emodin Attenuate Non-Alcoholic Fatty Liver Disease in Zebrafish by Regulation of AMPK Signaling Pathway</p>. Drug Design Development and Therapy. Volume 14. 1493–1506. 44 indexed citations
10.
Hu, Naihua, Cheng Wang, Xuyang Dai, et al.. (2019). Phillygenin inhibits LPS-induced activation and inflammation of LX2 cells by TLR4/MyD88/NF-κB signaling pathway. Journal of Ethnopharmacology. 248. 112361–112361. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026